Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).

about

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).

Item

http://www.wikidata.org/entity/Q54963093

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@en

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@nl

type

Item

label

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@en

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@nl

prefLabel

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@en

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@nl

P1476

Eribulin for metastatic breast ...... , south Italy (Eri-001 trial).

@en

P2093

Adriano Gravina

http://www.w3.org/2001/XMLSchema#string

Agata Pisano

http://www.w3.org/2001/XMLSchema#string

Alessio Fabozzi

http://www.w3.org/2001/XMLSchema#string

Anna Diana

http://www.w3.org/2001/XMLSchema#string

Antonio Febbraro

http://www.w3.org/2001/XMLSchema#string

Carmela Mocerino

http://www.w3.org/2001/XMLSchema#string

Enrico Barbato

http://www.w3.org/2001/XMLSchema#string

Eugenio Procaccini

http://www.w3.org/2001/XMLSchema#string

Eva Lieto

http://www.w3.org/2001/XMLSchema#string

Ferdinando Riccardi

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data

Systematic review of ixabepilone for treating metastatic breast cancer.

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.

Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.

Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life.

P304

e000176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2017-000176

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fortunato Ciardiello

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28761747

http://www.w3.org/2001/XMLSchema#string

P921

An Eadailt

P932

5519815

http://www.w3.org/2001/XMLSchema#string